Results 201 to 210 of about 41,193 (285)

Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS

International Forum of Allergy &Rhinology, Volume 16, Issue 9, Page 986-995, September 2026.
ABSTRACT Background A greater benefit of biologics is observed after surgery in Type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). However, the extent of surgery remains undefined in many studies. This study evaluated the extent of surgery on disease control in patients receiving biologics for refractory Type 2 dominant CRSwNP.
Nicholas J. Campion, Peta‐Lee Sacks, Lu Hui Png, Ruoxin Hua, Rhea Darbari Kaul, Raquel Alvarado, Christine Choy, Raymond Sacks, Peter Earls, Raewyn G. Campbell, Larry Kalish, Richard J. Harvey   +11 more
wiley   +1 more source

Comparative Outcomes of Amoxicillin and Amoxicillin-Clavulanate in the Treatment of Acute Rhinosinusitis in Adults with Comorbidities: A Retrospective Study. [PDF]

Antibiotics (Basel)
Miron RY, Perlov Gavze R, Vered S, Shapiro Ben David S, Liran O.   +4 more
europepmc   +1 more source

Chronic Rhinosinusitis and Nasal Polyps in Eosinophilic Granulomatosis With Polyangiitis: A Scoping Review

International Forum of Allergy &Rhinology, Volume 16, Issue 9, Page 996-1011, September 2026.
ABSTRACT Background Chronic rhinosinusitis (CRS) is one of the most common manifestations of eosinophilic granulomatosis with polyangiitis (EGPA), often preceding the diagnosis of systemic vasculitis by several years. The sinonasal presentation of EGPA typically resembles CRS with nasal polyps (CRSwNP), making it clinically indistinguishable from those
Alisha Sharma, Alyssa Y. Li, Teruko Kishibe, Dennis Wong, Kevin M. Sanders, Maggie Jiang, Heedo Lee, Christine Song, Kieran Mcintyre, Christian Pagnoux, Yvonne Chan, John M. Lee, Daniel J. Lee   +12 more
wiley   +1 more source

Behind the Unilateral Rhinorrhea: Delayed Pediatric Intranasal Foreign Bodies Presenting as Chronic Sinonasal Disease and Severe Complications. [PDF]

Pediatr Rep
Papadopoulos C, Dinaki K, Gravalidou I, Ioannidis R.   +3 more
europepmc   +1 more source

Assessing Surgical Extent Before Biologic Therapy for CRSwNP

International Forum of Allergy &Rhinology, Volume 16, Issue 9, Page 1043-1045, September 2026.
Key Points Nearly two‐thirds of patients had no surgery or incomplete sinus surgery before biologics. Among all sinuses, the frontal sinus was the least frequently addressed before biologics.
Alison J. Yu, Kristina A. LaPointe, Kaitlyn Ann Roberts, Michelle Yu, James N. Palmer, Alan D. Workman, Jose L. Mattos, Rodney J. Schlosser, Zachary M. Soler   +8 more
wiley   +1 more source

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis. [PDF]

ERJ Open Res
Shteinberg M, Haworth CS, Pollock J, Cohen S, Loebinger MR, Jrbashyan J, Dimakou K, Abo Helo N, Aliberti S, Stein N, Ringshausen FC, Adir Y, De Soyza A, Vendrell M, Burgel PR, Sibila O, Bossios A, Lind H, Viligorska K, Robertson K, Kauppi P, Milenkovic B, Menendez R, Munteanu O, Obradovic D, Nowinski A, Amorim A, Torres A, Lorent N, Van Braeckel E, Anwar M, Battalglia S, Shoemark A, Boersma W, Goeminne PC, Blasi F, Polverino E, Chalmers JD.   +37 more
europepmc   +1 more source

Diet, Nutrition, and Rhinosinusitis: A Systematic Review of Dietary Interventions and Exposures. [PDF]

Nutrients
Martinez C, Sitkowski EM, Martinez ME, Martinez E, Patel PN, Walsh HL, Khalili S.   +6 more
europepmc   +1 more source

Rhinosinusitis with nasal polyposis

, 2016
Reh, Douglas D., Woodworth, Bradford A., Poetker, David M., S. Karger GmbH   +3 more
core  

Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives. [PDF]

Medicina (Kaunas)
Aigozhina B, Tulebaeyv R, Azhenov T, Dzhandayev S, Papulova N, Zhankina R, Sagandykova K.   +6 more
europepmc   +1 more source

Phenotypic Clusters of Severe Asthma and Response to Dupilumab in Real‐World Practice

Clinical and Translational Allergy, Volume 16, Issue 9, September 2026.
ABSTRACT Background Severe asthma is a heterogeneous disease with variable clinical and inflammatory profiles that may influence responses to biological therapies. Identifying phenotypic clusters may help optimize patient selection and treatment outcomes.
Daria S. Fomina, Sergey V. Fedosenko, Аnton А. Chernov, Elena N. Bobrikova, Оlga А. Mukhina, Marina S. Lebedkina, Alexander V. Karaulov, Asel Yu. Nurtazina, Mariana A. Lysenko, Harald Renz   +9 more
wiley   +1 more source